Viemed Healthcare, Inc. (VMD) News
Filter VMD News Items
VMD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VMD News Highlights
- For VMD, its 30 day story count is now at 4.
- Over the past 19 days, the trend for VMD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DEC are the most mentioned tickers in articles about VMD.
Latest VMD News From Around the Web
Below are the latest news stories about VIEMED HEALTHCARE INC that investors may wish to consider to help them evaluate VMD as an investment opportunity.
Should You Hold Viemed Healthcare (VMD)?Wasatch Global Investors, an investment management firm, released its “Wasatch Micro Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark during the quarter. The quality-oriented positioning was the main reason for the strategy’s outperformance in the quarter. In addition, please check the fund’s […] |
Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?Key Insights Viemed Healthcare's estimated fair value is US$15.02 based on 2 Stage Free Cash Flow to Equity Viemed... |
What Does Viemed Healthcare, Inc.'s (TSE:VMD) Share Price Indicate?Viemed Healthcare, Inc. ( TSE:VMD ), is not the largest company out there, but it saw a double-digit share price rise... |
Viemed to Centralize Market for Common Shares on NASDAQ Through Voluntary Delisting from TSXLAFAYETTE, La., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has applied and received approval from the Toronto Stock Exchange (“TSX”) for the voluntary delisting of its common shares (each a “Common Share”) from the TSX. The delisting from TSX will not affect the Company's listing on the NASDAQ Capital Market ("NASD |
Viemed Healthcare, Inc. (TSE:VMD) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?Most readers would already be aware that Viemed Healthcare's (TSE:VMD) stock increased significantly by 23% over the... |
Is Viemed Healthcare, Inc. (TSE:VMD) Trading At A 50% Discount?Key Insights Viemed Healthcare's estimated fair value is CA$20.77 based on 2 Stage Free Cash Flow to Equity Current... |
Viemed Healthcare to Present at Stifel 2023 Healthcare ConferenceLAFAYETTE, La., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will participate in the Stifel 2023 Healthcare Conference on November 15, 2023, in New York, New York at the Lotte New York Palace Hotel, located at 455 Madison Ave. Casey Hoyt, CEO, and Todd Zehnder, COO, will conduct a presentation that will cover k |
Viemed Healthcare Inc (VMD) Reports Record Q3 2023 Financial ResultsNet Revenues and Net Income Surge by 38% and 177% Respectively |
Viemed Healthcare Announces Record Third Quarter 2023 Financial ResultsLAFAYETTE, La., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2023. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended September 30, 2023 reached a new Company record of $49.4 million, repres |
Viemed Healthcare Announces Date and Time for Conference CallLAFAYETTE, La., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, November 2, 2023 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)+1 201-689-8451 (International) Financial professionals are invited to call i |